Draft Agenda (as of Jan. 16, 2007)
January 23, 2006, NSF, Arlington, VA (Room 110, Stafford I)
- 08:00-08:30
Continental Breakfast
- 08:30-08:40 Welcome and Overview
- Michael Reischman, Deputy Assistant Director, NSF/ENG
- Duane Shelton, President, WTEC
- 08:40-09:00 WTEC
International Assessment of Vaccine Manufacturing
- Joe Bielitzki, University of Central Florida
- Presentation (pdf format)
I. Can Current Vaccine Manufacturing Strategy Meet Future
Vaccine Needs?
- 09:00-9:30 Regulation of Vaccines:
Challenges
and
Opportunities
- Erik Henchal, U.S. Food and Drug Administration
- Presentation (pdf format)
- 09:30-10:00 Rotavirus Vaccines -
A Case Study
- 10:00-10:10
Commentary/Moderator:
Terry
Leighton,
Children’s Hosp. Oakland Res. Institute
- 10:10-10:25
Break
II. Can Vaccine Manufacture be Agile, Modular and Responsive?
- 10:25-10:55 Large-Scale Vaccine
Manufacture
- Dr. Shou-Bai Chao, Wyeth Laboratories
- Presentation
(pdf format)
- 10:55-11:25 Single-Use
Bioreactors; Rapid Process
Development and Scale-Up
- 11:25-11:55 What Limits the Rate
of Vaccine
Development and Scale-Up?
- 11:55-12:05
Commentary/Moderator:
Dr. Mary Ritchey,
Ritchey Associates, Inc.
- 12:05-13:10Lunch
III. Incorporating Innovation in Bioprocessing
- 13:10-13:40 The Front-End of
Vaccine Manufacturing: Getting Good Candidates from
the Get-Go
- 13:40-14:10 Measuring and
Optimizing
Process Performance
- 14:10-14:40 Miniaturizing
Development and Manufacture of Biologics
- 14:40-14:55
Commentary/Moderator:
Joe Bielitzki
- 14:55-15:10
Break
IV. The Changing Face of Vaccine Development
- 15:10-15:40 Concepts Regarding Adenovirus based Vaccine
Systems
- Dr. Andrea Amalfitano, Michigan State University
- Presentation (pdf format)
- 15:40-16:10 Total Synthesis and
Assembly of a Virus
Like Particle
- Prof. Jim Swartz , Stanford University
- Presentation
(pdf format)
- 16:10-16:20
Commentary/Moderator:
Steve Drew,
Science Partners LLC
- 16:20-16:45
Discussion and
Wrap-Up